Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
763,606
-
Shares change
-
+159,907
-
Total reported value, excl. options
-
$11,426,133
-
Value change
-
+$2,304,096
-
Number of buys
-
14
-
Number of sells
-
-11
-
Price
-
$14.94
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2015
36 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2015.
XBiotech Inc. - Common Shares, no par value (XBIT) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 763,606 shares
of 33,289,095 outstanding shares and own 2.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (251,636 shares), BlackRock Fund Advisors (104,633 shares), GOLDMAN SACHS GROUP INC (53,462 shares), Forest Hill Capital, LLC (45,000 shares), NORTHERN TRUST CORP (44,739 shares), GEODE CAPITAL MANAGEMENT, LLC (39,896 shares), BlackRock Institutional Trust Company, N.A. (33,151 shares), M Holdings Securities, Inc. (26,833 shares), STATE STREET CORP (23,470 shares), and BEACON FINANCIAL GROUP (20,000 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.